BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/3/2014 10:38:00 AM | Browse: 962 | Download: 710
Publication Name World Journal of Clinical Pediatrics
Manuscript ID 2954
Country United States
Received
2013-03-28 09:33
Peer-Review Started
2013-03-29 10:08
To Make the First Decision
2013-05-02 10:35
Return for Revision
2013-05-17 16:00
Revised
2013-05-30 04:04
Second Decision
2013-07-01 12:07
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-07-01 23:44
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-07-11 19:00
Publish the Manuscript Online
2013-11-08 10:03
ISSN 2219-2808 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Pediatrics
Manuscript Type Autobiography
Article Title Tramadol use in pediatric sickle cell disease patients with vaso-occlusive crisis
Manuscript Source Invited Manuscript
All Author List Mary P Borgerding, Randall K Absher and Tsz-Yin So
Funding Agency and Grant Number
Corresponding Author Tsz-Yin So, PhD, BCPS, Department of Pharmacy, Moses H. Cone Memorial Hospital, 1200 N. Elm St., Greensboro, NC 27401, United States. jeremy.so@conehealth.com
Key Words Pediatrics; Sickle cell; Tramadol; Morphine; Vaso-occlusive crisis
Core Tip A small clinical study has shown that balanced analgesia using intravenous morphine, intravenous ketorolac, and intravenous tramadol followed by erythrocytapheresis was effective, as shown by pain relief and significant improvement in mood and sleep, in seven sickle cell disease patients aged three to twenty-eight years who presented with vaso-occlusive crisis. The objective of this study is to evaluate whether the addition of scheduled oral tramadol to intravenous morphine plus intravenous ketorolac provides adequate pain relief, and reduces morphine requirements, adverse effects, length of patient-controlled analgesia therapy, and length of hospital stay.
Publish Date 2013-11-08 10:03
Citation Borgerding MP, Absher RK, So TY. Tramadol use in pediatric sickle cell disease patients with vaso-occlusive crisis. World J Clin Pediatr 2013; 2(4): 65-69
URL http://www.wjgnet.com/2219-2808/full/v2/i4/65.htm
DOI http://dx.doi.org/10.5409/wjcp.v2.i4.65
Full Article (PDF) WJCP-2-65.pdf
Manuscript File 2954-Review.doc
Answering Reviewers 2954-Answering reviewers.pdf
Copyright License Agreement 2954-Copyright assignment.pdf
Peer-review Report 2954-Peer review(s).pdf
Scientific Editor Work List 2954-Scientific editor work list.doc